Search results
Kiora Pharmaceuticals director buys $25,668 in company stock By Investing.com
Investing.com· 14 hours agoOn June 13, 2024, Parsons acquired 5,260 shares of common stock at a price of $4.88 per share. This...
Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX) By...
Investing.com· 9 hours agoFollowing this transaction, the insider now owns 98,869.475 shares of the company. Pacira...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Down Following Insider Selling
ETF DAILY NEWS· 9 hours agoUltragenyx Pharmaceutical shares last traded at $43.72, with a volume of 62,032 shares trading hands. Specifically, EVP Karah Herdman Parschauer sold 9,806 shares of the & ...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 7 days agocompany has been reinvesting all of its profits into the business. This is likely what's driving the...
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 11 hours agoOn June 12, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex ...
Pacira BioSciences COO sells shares worth $28,380 By Investing.com
Investing.com· 12 hours agoPacira BioSciences, Inc. (NASDAQ:PCRX), a pharmaceutical company specializing in non-opioid pain...
Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening
Charlotte Observer via Yahoo Finance· 15 minutes agoCol. Eli Lilly founded the Indianapolis-based pharmaceutical company in 1876. Eli Lilly employs...
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher
ETF DAILY NEWS· 8 hours agoTelomir Pharmaceuticals, Inc. (NASDAQ:TELO – Get Free Report) shares were up 2.2% during trading on Thursday . The stock traded as high as $6.28 and last traded at $5.63.
Q2 2024 EPS Estimates for Longboard Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:LBPH)
ETF DAILY NEWS· 9 hours agoLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Equities research analysts at B. Riley dropped their Q2 2024 EPS estimates for Longboard Pharmaceuticals ...
Insider Sale: SVP, Chief Technology Officer Silji Abraham Sells Shares of West Pharmaceutical ...
GuruFocus.com via Yahoo Finance· 11 hours agoOn June 12, 2024, Silji Abraham, Senior Vice President and Chief Technology Officer of West ...